Business decision making in a commercial organization is both an art and a science. The Lifesciences (pharmaceutical/medical devices) industry is no different in that sense. Being right on questions such as whether to invest or divest and whether to acquire or license mandates well informed decision making. With the new trends emerging such as increased cost pressures, shrinking pipelines, need for focus on impact and outcomes, adoption of newer technologies, terabytes of data, changing customer preferences, and changing stakeholders, affecting the dynamics of the lifesciences industry, it is extremely critical to take the right decisions at the right time.
Indegene commercial analytics has the capacity and capability to mirror any Lifesciences (pharmaceutical/medical devices) organization in 3 critical steps of business decision making -
Domain Knowledge: Through a team of expert scientific and market researchers and data scientists and modelers with a deep knowledge of the pharmaceutical industry we have rich practical experience of working with all the major pharmaceutical companies in developed and emerging geographies.
End-to-end Services: We provide services spanning across all the major functions within a lifesciences company, from R&D to medical to marketing and sales operations and global strategy functions. Our key solutions include commercial effectiveness, market and competitor intelligence, decision sciences, and technology-oriented solutions for clients.
Investments in Platforms, Tools, and Capabilities: In order to deliver a variety of solutions to our clients, we have made critical investments in developing our own proprietary platforms, frameworks, processes, and capabilities.
Indegene’s Commercial Effectiveness and Decision Sciences solutions include forecasting, multichannel marketing analytics, reporting and visualization, and advanced analytics services (customer segmentation, ROI measurement and pathways analysis, optimal channel mix, channel and content preference assessment to name a few). We also provide technology-based solutions for clients depending on their needs, for example, Web-based forecasting solutions, analog selection platform, KOL management platform, and performance management solutions. Our market and competitive intelligence solutions include R&D analytics and insights, pipeline analysis, competitive intelligence, KOL identification and profiling, market research, and market access insights.
Our skilled teams comprise MDs; MDSs; PhDs; Lifesciences, Engineering, and Statistics graduates and post graduates with experience in working across multiple therapy areas, technologies, clients, and geographies. Indegene's ability to work through different engagement models such as centers of excellence, extended enterprise engagements, consultation, FTE-based models, and, when needed, a mix of 2 or more of these as well as established platforms and methodologies allow for efficient and value-added interactions with clients.
Global footprint; resource flexibility; and cost-effective solutions, tools, and frameworks
Leveraging of deep domain knowledge to provide strategic and actionable insights
Applying output- and evidence-driven “outside-in” commercial models focused on stakeholder needs (physician, patients, and payers)
Multichannel analytics using complex and multidimensional data, varied models, and results interpretation
Access to Indegene’s significant intellectual property (IP) in areas such as new commercial models, forecasting, marketing mix modeling, sales/MCM KPI frameworks, benchmarks and clinical analytics
Analyzing the importance of emerging markets through data paucity and local market knowledge required for decision making
Flexible engagement models to provide continuous market and business intelligence coupled with actionable insights
Tailor-made and technology-based solutions to cater to complex business needs
Indegene's competitive intelligence capability focuses on helping clients understand the current and emerging competition across therapy areas, closely monitors the dynamics of the pharmaceutical market, and helps clients make strategic decisions. LEARN MORE.
Through Indegene's health economics and outcomes research (HEOR) services, we assist clients in generating evidence to differentiate client products for better market access and value proposition. LEARN MORE.
Indegene offers information and knowledge services to enable clients access detailed information through user-friendly databases and reports.
Indegene's data analytics solutions are catered towards formulating new strategies and forecasts for pipeline and marketed products.
Through Indegene's multichannel marketing (MCM) analytics services, they formulate market mix models to help clients optimize and position their MCM initiatives. LEARN MORE.